- Home
- FTHM vs CRIS Comparison
FTHM vs CRIS Comparison
Compare FTHM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- CRIS
- Stock Information
- Founded
- FTHM 2010
- CRIS 2000
- Country
- FTHM United States
- CRIS United States
- Employees
- FTHM N/A
- CRIS N/A
- Industry
- FTHM Real Estate
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTHM Finance
- CRIS Health Care
- Exchange
- FTHM Nasdaq
- CRIS Nasdaq
- Market Cap
- FTHM 32.8M
- CRIS 32.8M
- IPO Year
- FTHM 2020
- CRIS 2000
- Fundamental
- Price
- FTHM $1.20
- CRIS $3.18
- Analyst Decision
- FTHM Strong Buy
- CRIS Strong Buy
- Analyst Count
- FTHM 4
- CRIS 3
- Target Price
- FTHM $4.25
- CRIS $23.00
- AVG Volume (30 Days)
- FTHM 97.2K
- CRIS 37.6K
- Earning Date
- FTHM 03-13-2025
- CRIS 02-18-2025
- Dividend Yield
- FTHM N/A
- CRIS N/A
- EPS Growth
- FTHM N/A
- CRIS N/A
- EPS
- FTHM N/A
- CRIS N/A
- Revenue
- FTHM $317,515,000.00
- CRIS $10,259,000.00
- Revenue This Year
- FTHM N/A
- CRIS N/A
- Revenue Next Year
- FTHM $28.50
- CRIS N/A
- P/E Ratio
- FTHM N/A
- CRIS N/A
- Revenue Growth
- FTHM N/A
- CRIS 0.44
- 52 Week Low
- FTHM $1.12
- CRIS $2.86
- 52 Week High
- FTHM $3.37
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- FTHM 36.35
- CRIS 46.32
- Support Level
- FTHM $1.12
- CRIS $3.15
- Resistance Level
- FTHM $1.36
- CRIS $3.55
- Average True Range (ATR)
- FTHM 0.12
- CRIS 0.22
- MACD
- FTHM 0.00
- CRIS 0.01
- Stochastic Oscillator
- FTHM 23.29
- CRIS 38.85
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.